CHAMPIONS ONCOLOGY, INC. Increase (Decrease) in Restricted Cash
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Increase (Decrease) in Restricted Cash of $0 for the 12-month period ending 2017-04-30, per its 10-K filed 2017-07-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2017-07-28
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for the quarter ending 2017-04-30 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for the quarter ending 2017-01-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for the quarter ending 2016-10-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for the quarter ending 2016-07-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for fiscal 2017 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for fiscal 2016 was -$13.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for fiscal 2015 was -$2.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for fiscal 2014 was -$27.00K, a 164.29% decline from fiscal 2013.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 9 month as first filed | Increase (Decrease) in Restricted Cash 12 month | Increase (Decrease) in Restricted Cash 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $0.00 derived: sum of 2 quarters · filed 2017-07-28 | $0.00 derived: sum of 3 quarters · filed 2017-07-28 | $0.00 10-K · filed 2017-07-28 | ||
| 2017-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | $0.00 derived: sum of 2 quarters · filed 2017-03-17 | $0.00 10-Q · filed 2017-03-17 | $0.00 derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2016-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | $0.00 10-Q · filed 2016-12-14 | $0.00 derived: sum of 3 quarters · filed 2017-07-28 | $0.00 derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2016-07-31 | $0.00 10-Q · filed 2016-09-14 | $0.00 derived: sum of 2 quarters · filed 2017-07-28 | $0.00 derived: sum of 3 quarters · filed 2017-07-28 | $0.00 derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2016-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $0.00 derived: sum of 2 quarters · filed 2017-07-28 | $0.00 derived: sum of 3 quarters · filed 2017-07-28 | -$13.00K 10-K · filed 2017-07-28 | ||
| 2016-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | $0.00 derived: sum of 2 quarters · filed 2017-03-17 | -$13.00K 10-Q · filed 2017-03-17 | -$13.00K derived: sum of 4 quarters · filed 2017-03-17 | ||
| 2015-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | -$13.00K 10-Q · filed 2016-12-14 | -$13.00K derived: sum of 3 quarters · filed 2016-12-14 | -$14.00K derived: sum of 4 quarters · filed 2016-12-14 | ||
| 2015-07-31 | -$13.00K 10-Q · filed 2016-09-14 | -$13.00K derived: sum of 2 quarters · filed 2016-09-14 | -$14.00K derived: sum of 3 quarters · filed 2016-09-14 | -$15.00K derived: sum of 4 quarters · filed 2016-09-14 | ||
| 2015-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$1.00K derived: sum of 2 quarters · filed 2016-07-29 | -$2.00K derived: sum of 3 quarters · filed 2016-07-29 | -$2.00K 10-K · filed 2016-07-29 | ||
| 2015-01-31 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | -$2.00K derived: sum of 2 quarters · filed 2016-03-16 | -$2.00K 10-Q · filed 2016-03-16 | -$1.00K derived: sum of 4 quarters · filed 2016-03-16 | ||
| 2014-10-31 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | -$1.00K 10-Q · filed 2015-12-15 | $0.00 derived: sum of 3 quarters · filed 2015-12-15 | -$29.00K derived: sum of 4 quarters · filed 2015-12-15 | ||
| 2014-07-31 | $0.00 10-Q · filed 2015-09-11 | $1.00K derived: sum of 2 quarters · filed 2015-09-11 | -$28.00K derived: sum of 3 quarters · filed 2015-09-11 | |||
| 2014-04-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | -$28.00K derived: sum of 2 quarters · filed 2015-07-29 | -$27.00K 10-K · filed 2015-07-29 | |||
| 2014-01-31 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | -$28.00K 10-Q · filed 2015-03-17 | ||||
| 2013-10-31 | $1.00K 10-Q · filed 2014-12-15 | |||||
| 2013-04-30 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28 | $42.00K derived: sum of 2 quarters · filed 2014-07-28 | $42.00K 10-K · filed 2014-07-28 | -$42.00K 10-K · filed 2013-07-26 | ||
| 2013-01-31 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-14 | $2.00K 10-Q · filed 2014-03-14 | -$2.00K 10-Q · filed 2013-03-13 | |||
| 2012-10-31 | $0.00 10-Q · filed 2013-12-13 | |||||
| 2012-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26 | $0.00 derived: sum of 2 quarters · filed 2013-07-26 | -$150.00K 10-K · filed 2013-07-26 | |||
| 2012-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-13 | -$150.00K 10-Q · filed 2013-03-13 | ||||
| 2011-10-31 | -$150.00K 10-Q · filed 2012-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |